UCB sketches grand plans for new headquarters as it grabs Eli Lilly's abandoned neuro R&D campus
Belgium’s UCB is set to invest more than £1 billion ($1.29 billion) in the UK over the next five years — starting with a brand new …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
